Brief: Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
29/09/2025 13:53
Sept 29 (Reuters) - Royalty Pharma PLC RPRX.O: ROYALTY PHARMA APPOINTS DR. TED W. LOVE AS LEAD INDEPENDENT DIRECTOR Source text: ID:nGNX8wyc39 Further company coverage: RPRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)